Inquire Now
  • Updates

Diaxxo’s Team keeps growing!

With Viviane joining, we are now 8 people working on the next generation of PoC PCR Diagnostics.

All essential areas of expertise are covered: from hardware (Edgar) to software (Viviane) and biology (Amalia and Tobias) as well as chemistry (Philippe). We are a truly diverse team and can count on valuable input from our consultants, whether on medical issues with Prof. Breyman, technical issues with Charles Tschaggeny, a former Biofire employee, or business discussions with Dr. Meier and Dr. Gianluigi.

Full of energy, we can’t wait to tackle all the challenges ahead of us and bring this truly great technology to market. Learn more about us!

Read More

  • Projects

One year passed from the “African-European partnership for development and deployment of rapid SARS-CoV-2 RNA and antigen detection assays”

  • Publication

Diaxxo AG Celebrates Innovation Triumph at Sino-Swiss Business Awards 2023

Subscribe to our newsletter!

    info@diaxxo.com
    +41 44 633 91 55

    HCI E 103, Vladimir ​Prelog Weg 1, 8093
    Zürich, Switzerland  

    Terms and Conditions
    Copyright © 2020-2022 diaxxo. All Rights Reserved.

    Covid Variants

    diaxxoPod (RUO)

    Description

    Our in-vitro diagnostic test cartridge based on rapid Polymerase Chain Reaction (PCR) amplification technology. This cartridge can reliably detect and distinguish the mutants from UK (20I/501Y.V1, B.1.1.7 – VOC-202012/01) as well as the South African mutation (B.1.351 lineage).

    The test cartridge is aimed to improve the public health situation by rapidly enabling the detection of variants of concern. The cartridge is designed for qualitative detection of variants of interest of the SARS-CoV-2 Viral RNA in saliva samples and it works in conjuction with diaxxoPCR.

    Specs

    • Fully preloaded and only require addition of purified sample
    • Results in approx. 30 minutes

    Workflow

    The test cartridges are sold with all the necessary reagents pre-loaded in the reaction wells. The use of the test cartridges is therefore extremely simple:

    • Apply the sample (viral RNA)
    • Apply water in the control wells and the cover fluid
    • Insert the cartrdige in diaxxoPCR, press a button, drink a coffee and check your results.

    Notes & Instructions

    • The cartridges are supplied in a vacuum-sealed bag in order to ensure a long shelf life at room temperature.
    • Detailed instructions about how to use the cartridges and the devices are provided

    SARS-CoV-2

    diaxxoPod

    Description

    This SARS-CoV-2 cartridge is based on the US Centers for Disease Control and Prevention (CDC) RT-PCR test for 2019-nCoV. The assay detects 2 parts of the N gene specific for Sars-CoV-2. In addition, an extraction control for Human RNAse P is also included. The cartridge is designed to work in combination with saliva samples and in conjuction with our diaxxoPCR.

    Specs

    • Functionally validated and confirmed template-free to cycle 45 by NTC testing
    •  Fully preloaded and only require addition of purified DNA/RNA
    • Results within 30 minutes

    Workflow

    The test cartridges are sold with all the necessary reagents pre-loaded in the reaction wells. The use of the test cartridges is therefore extremely simple:

    • Apply the sample (viral RNA)
    • Apply water in the control wells and the cover fluid
    • Insert the cartrdige in diaxxoPCR, press a button, drink a coffee and check your results.

    Notes & Instructions

    • The cartridges are supplied in a vacuum-sealed bag in order to ensure a long shelf life at room temperature.
    • Detailed instructions about how to use the cartridges and the devices are provided

    Cookies

    We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

    Reject all
    Accept all